ZM447439
Jump to navigation
Jump to search
Names | |
---|---|
Preferred IUPAC name
N-[4-({6-Methoxy-7-[3-(morpholin-4-yl)propoxy]quinazolin-4-yl}amino)phenyl]benzamide | |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C29H31N5O4 | |
Molar mass | 513.598 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
ZM447439 is an aurora inhibitor.[1]
References
- ^ Georgieva, I.; Koychev, D.; Wang, Y.; Holstein, J.; Hopfenmüller, W.; Zeitz, M.; Grabowski, P. (2010). "ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines". Neuroendocrinology. 91 (2): 121–130. doi:10.1159/000258705. PMID 19923785. S2CID 1042055.
Categories:
- Articles without KEGG source
- Articles with changed ChemSpider identifier
- Articles with changed InChI identifier
- Articles containing unverified chemical infoboxes
- Chembox image size set
- Articles with short description
- Short description matches Wikidata
- All stub articles
- Pharmacology stubs
- Protein kinase inhibitors
- Quinazolines
- 4-Morpholinyl compounds
- Benzamides